Related Experiment Video
Updated: Jun 14, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Epigenetic changes in the myelodysplastic syndrome
1Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe, Houston, TX 77030, USA. jpissa@mdanderson.org
Hematology/Oncology Clinics of North America
|April 3, 2010
Summary
Epigenetic changes like DNA methylation are key in myelodysplastic syndrome (MDS). Treatments targeting these epigenetic pathways offer hope for managing MDS and preventing acute myeloid leukemia.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic mechanisms, including DNA methylation and histone modifications, regulate gene expression and can mediate pathway dysfunction in cancer.
- Myelodysplastic syndrome (MDS) frequently exhibits epigenetic abnormalities, notably hypermethylation of genes controlling proliferation and adhesion.
- Aberrant DNA hypermethylation in MDS correlates with a poor prognosis and accelerated progression to acute myeloid leukemia.
Purpose of the Study:
- To explore the role of epigenetic mechanisms in the pathogenesis of myelodysplastic syndrome (MDS).
- To investigate the prognostic significance of DNA hypermethylation in MDS.
- To evaluate the therapeutic potential of epigenetic modifying drugs in MDS management.
Main Methods:
- Review of current literature on epigenetic mechanisms in neoplasia.
- Analysis of studies linking DNA methylation patterns to MDS prognosis and progression.
- Examination of clinical trial data for epigenetic therapies in MDS.
Main Results:
- Epigenetic alterations are central to MDS development and progression.
- DNA hypermethylation is a significant adverse prognostic factor in MDS.
- DNA methylation and histone deacetylation inhibitors have demonstrated efficacy in treating MDS.
Conclusions:
- Epigenetic dysregulation is a critical driver of MDS.
- Targeting epigenetic pathways with specific inhibitors offers a promising therapeutic strategy for MDS.
- Epigenetic therapies can induce durable remissions and improve survival in MDS patients.
Related Concept Videos
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...